NIAID-VRC- Rapid Manufacturing Response — DAVID LINDSAY (LEIDOS BIOMEDICAL RESEARCH, INC.)
The Vaccine Research Center (VRC) mission and scope includes rapidly moving clinical candidates from the research bench through development and GMP manufacturing to the clinic. The VRC is exploring a
| Project title | NIAID-VRC- Rapid Manufacturing Response |
|---|---|
| Project number | 75N91019D00024-0-759102200002-1 |
| PI name | DAVID LINDSAY |
| Institution | LEIDOS BIOMEDICAL RESEARCH, INC. |
| Funding mechanism | N01 |
| Agency | NIAID |
| Award amount | $9.82M |
| Fiscal year | 2022 |
| Project start | 2022-09-16T00:00:00 |
| Project end | 2027-09-15T00:00:00 |
| Abstract | The Vaccine Research Center (VRC) mission and scope includes rapidly moving clinical candidates from the research bench through development and GMP manufacturing to the clinic. The VRC is exploring a |
| Key terms | <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><AIDS Virus><Acquired Immune Deficiency |
$799/mo
Try GrantRadar →